
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma”, Cancer Med, 2019.
, “Diabetes, use of antidiabetic drugs, and the risk of glioma”, Neuro Oncol, vol. 18, pp. 340-9, 2016.
, “Diabetes, use of metformin, and the risk of meningioma”, PLoS One, vol. 12, p. e0181089, 2017.
, “Metabolic syndrome in relation to risk of meningioma”, Oncotarget, vol. 8, pp. 2284-2292, 2017.
, “Statin use and risk of glioma: population-based case-control analysis”, Eur J Epidemiol, vol. 31, pp. 947-52, 2016.
, “Use of cardiac glycosides and risk of glioma”, J Neurooncol, vol. 127, pp. 321-8, 2016.
, “Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma”, PLoS One, vol. 11, p. e0149293, 2016.
,